COVID-19 “VACCINES”: THE WRONG BOMB OVER THE WRONG TARGET AT THE WRONG TIME

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

by Ronald Neil Kostoff

This OpEd will show that the present mainline “vaccines” being deployed against COVID-19 during the “pandemic” are ineffective in preventing viral infection and transmission, are harmful to the host, and enable the escape and propagation of viral mutants.

1. “Vaccine” Ineffectiveness

We live in a sea of viruses named the virome.  We are continually exposed to these viruses; we can no more avoid them than we can avoid the oxygen in the air we breathe or the hydrogen in the water we drink.  In fact, it is this continual interaction of the host with myriad viruses that potentially increases robustness and functionality of the host’s immune system.

Whether or not this exposure results in infection and serious disease depends on the pathogenicity of the virus and health of the host’s immune system.  If the immune system is dysfunctional, it will be unable to fully neutralize any pathogenic virus. For the SARS-CoV-2 virus, the dysfunctional immune system will allow the virus to enter and replicate in cells and trigger a chain of events, ultimately leading to COVID-19.

The main source of SARS-CoV-2 viral entry is through inhalation, and somewhat less through ingestion.  An effective vaccine would focus on cellular immunity in the respiratory and intestinal tract, in which secretory IgA is produced by “immune cells (lymphocytes) that are located directly underneath the mucous membranes that line the respiratory and intestinal tract. The antibodies produced by these lymphocytes are ejected through and to the surface of the linings. These antibodies are thus on site to meet air-borne viruses and they may be able to prevent viral binding and infection of the cells

Unfortunately, the main inoculants used presently for COVID-19 focus on antibodies (IgG and circulating IgA) that occur in the bloodstream. “These antibodies protect the internal organs of the body from infectious agents that try to spread via the bloodstream.

Vaccines that are injected into the muscle – i.e., the interior of the body – will only induce IgG and circulating IgA, not secretory IgA. Such antibodies cannot and will not effectively protect the mucous membranes from infection by SARS-CoV-2. Thus, the observed “breakthrough infections” merely confirm the fundamental design flaws of the vaccines. Measurements of antibodies in the blood can never yield any information on the true status of immunity against infection of the respiratory tract.”

a natural infection with SARS-CoV-2 (coronavirus) will in most individuals remain localized to the respiratory tract.  The vaccines used presently “cause cells deep inside our body to express the viral spike protein, which they were never meant to do by nature. Any cell which expresses this foreign antigen on its surface will come under attack by the immune system, which will involve both IgG antibodies and cytotoxic T-lymphocytes. This may occur in any organ, but the damage will be most severe in vital organs. We are seeing now that the heart is affected in many young people, leading to myocarditis or even sudden cardiac arrest and death.”.

In other words, we are dropping the wrong bomb on the wrong target at the wrong time!

2. “Vaccine” Harm to Host

“There are at least three types of toxicities associated with the inoculant. The spike protein resulting from the inoculant is extremely toxic….The LNP encapsulating shell has some extremely toxic components, such as polyethylene glycol, to which many people are sensitive…..and cationic lipids.  The desired product of the inoculations, anti-spike protein antibodies, can react with tissues and cause myriad types of damage”

The inoculant “evades the immune system in two ways.  It is injected, thereby entering the bloodstream directly and indirectly, and by-passing that part of the innate immune system that inhaled viruses encounter initially.  The LNP-encapsulating shell, which provides mRNA stability, was developed initially for drug delivery and similar applications, where the target is to deliver drugs to any tissue or organ in the body. In this case, increased time spent in the circulatory system is the goal.  For the present application, long residence time in the circulatory system means that the vascular damage and clotting associated with the spike protein endocytic merging with the endothelial cells can occur throughout the body.  This impact is seen in the types of damage listed in VAERS, and in post-inoculation autopsies. Third, while it boosts the antibody titers for a few months, it affects the immune system adversely.”

The combination of multiple toxicities and stealth operation (immune system evasion) produce damage to all tissues and organs. Steve Kirsch has documented many of these symptoms and diseases in a comprehensive slide presentation. 

It should also be remembered that these adverse effects occurred a relatively short time after inoculation (few months).  The mid-term and long-term effects are unknown at this time (having never been assessed during the very brief clinical trials), but Early Warning Indicators appear ominous

Additionally, “Studies from the UK and Sweden, among many others, seem to indicate that the second mRNA dose confers immunity for about six months, after which a booster is required to maintain immunity. This could mean that boosters would be required every six months (or sooner) indefinitely, and each booster would be accompanied by adverse effects (such as the micro-clotting that Dr. Hoffe has reported in his patients). If these effects are cumulative and irreversible, that would spell disaster for those on the endless treadmill of booster—short-term immunity—waning immunity—possible negative effectiveness—booster…..”. Multiple inoculations could lead to effective destruction of the immune system, opening the door to massive increases in disease presently kept in check by a functioning immune system.

3.  “Vaccines’” Enabling of Mutations/Variants

Dr. Geert Vanden Bossche has been emphasizing in public (since March 2021) the dangers of prophylactic vaccination during a pandemic, and the enabling of more infectious variants that allow the virus to escape the higher immune pressure due to the increased antibodies.  One of his more recent statements describes this phenomenon in detail.  He concludes:

“Mass vaccination is now turning Covid-19 into a disease of young and healthy unvaccinated people while enabling the virus to break through both the innate and adaptive immune defense of vaccinees due to vaccine-mediated suppression of innate Abs and viral resistance to vaccinal Abs, respectively. For those who didn’t get it thus far, Omicron will repeat that lesson; its teaching will only be a bit tougher and will soon silence all those who are trying to convince their people that they can outsmart the virus and, as they ridiculously claim, ‘stay ahead of the virus’.”

4. Conclusions

The above analysis shows that even if prophylactic vaccination had been done before the pandemic, the “vaccines” would have been ineffective, given that they are focused on the wrong target.  Administering them during the pandemic prolongs the pandemic by forcing the virus to mutate into variants to escape the high immune pressure.

Based on the studies of our group, the priority of corrective actions to avoid future pandemics should be as follows:

*Eliminate those factors that contribute to immune system dysfunction

*Initiate prophylactic treatment with safe supplements and drugs

*If symptoms appear, start early treatment with repurposed drugs, especially anti-virals

*Quarantine most vulnerable individuals

*Administer adequately tested and safe innate immune vaccines

DISCLAIMER: This OpEd does not provide medical advice.  The information contained in this OpEd is for informational purposes only. No material in this paper is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen.  Never disregard professional medical advice or delay in seeking it because of something you have read in this paper.

Ronald Neil Kostoff received a Ph. D. in Aerospace and Mechanical Sciences from Princeton University in 1967. He has worked for Bell Laboratories, Department of Energy, Office of Naval Research, and MITRE Corp. He invented the Wake Shield for producing high vacuum in low orbit, and used in manned space missions for research and development. He has published over 200 peer-reviewed articles, served as Guest Editor of four journal Special Issues since 1994, obtained two text mining system patents, and presently is an Independent Consultant. He has published on numerous medical topics in the peer-reviewed literature, including: 1) potential treatments for Multiple Sclerosis, Parkinson’s Disease, Raynaud’s Phenomenon, Cataracts, SARS, Inflammatory Bowel Disease, Vitreous Restoration; 2) protocols for preventing and reversing Peripheral Neuropathy/Peripheral Arterial Disease, Alzheimer’s Disease, Chronic Kidney Disease; 3) potential causes of Chronic Kidney Disease, Alzheimer’s Disease, Peripheral Neuropathy/Peripheral Arterial Disease; and 4) potential impacts of Electromagnetic Fields on health, synergistic effects of toxic stimuli combinations, COVID-19 prevention strategies and vaccine safety issues, and unified theory of chronic-infectious diseases. He is listed in: “Who’s Who in America” (60th Edition-2006), “Who’s Who in Science and Engineering” (9th Edition 2006), and “2000 Outstanding Intellectuals of the 21st Century” (4th Edition 2006).